SPRB (STOCKS)
Spruce Biosciences, Inc. Common Stock
$64.510000
+0.880000 (+1.38%)
Prev close: $63.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Javier Szwarcberg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $88.83M
- Employees
- 20
- P/E (TTM)
- -1.21
- P/B (TTM)
- 2.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-11.28 | $-8.15 | -3.1346 | -38.48% |
|
Sep 2025 (Q3)
|
$-14.58 | $-14.21 | -0.3663 | -2.58% |
|
Jun 2025 (Q2)
|
$-3.50 | $-19.51 | +16.0075 | +82.06% |
|
Mar 2025 (Q1)
|
$-24.00 | $-16.42 | -7.5831 | -46.19% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $36.51M |
| Depreciation and Amortization | $21.00K |
| Research and Development | $19.52M |
| Other Operating Expenses | $16.97M |
| Operating Income/Loss | -$36.51M |
| Income/Loss From Continuing Operations After Tax | -$38.97M |
| Income/Loss From Continuing Operations Before Tax | -$38.97M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $90.00K |
| Net Income/Loss | -$38.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$50.83 |
| Diluted Earnings Per Share | -$50.83 |
| Basic Average Shares | 766,598 |
| Diluted Average Shares | 766,598 |
| Assets | $53.02M |
| Current Assets | $52.11M |
| Cash | $48.90M |
| Prepaid Expenses | $353.00K |
| Other Current Assets | $2.86M |
| Noncurrent Assets | $909.00K |
| Liabilities | $10.51M |
| Current Liabilities | $10.09M |
| Accounts Payable | $943.00K |
| Other Current Liabilities | $9.14M |
| Noncurrent Liabilities | $419.00K |
| Equity | $42.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $42.52M |
| Liabilities And Equity | $53.02M |
| Net Cash Flow From Operating Activities | -$33.33M |
| Net Cash Flow From Operating Activities, Continuing | $33.30M |
| Net Cash Flow From Investing Activities | -$10.15M |
| Net Cash Flow From Investing Activities, Continuing | -$76.78M |
| Net Cash Flow From Financing Activities | $43.48M |
| Net Cash Flow From Financing Activities, Continuing | $43.48M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$38.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.97M |
| Other Comprehensive Income/Loss | $0.00 |